411 related articles for article (PubMed ID: 15015016)
21. [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism].
Ruiz-Rizzo AL; Tirado V; Moreno-Carrillo C; Aguirre-Acevedo DC; Murillo O; Lopera F
Rev Neurol; 2009 Aug 1-15; 49(3):123-30. PubMed ID: 19621306
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases.
Chiò A; Magnani C; Schiffer D
Mov Disord; 1998 May; 13(3):400-5. PubMed ID: 9613728
[TBL] [Abstract][Full Text] [Related]
23. Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data.
Swarztrauber K; Anau J; Peters D
Mov Disord; 2005 Aug; 20(8):964-70. PubMed ID: 15834854
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics of Parkinson's disease in natural population].
Huang JB; Zhang ZX; Wu JX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):19-22. PubMed ID: 12905811
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease.
Racette BA; Rundle M; Parsian A; Perlmutter JS
Am J Med Genet; 1999 Oct; 88(5):539-43. PubMed ID: 10490713
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of parkinsonian signs and associated mortality in a community population of older people.
Bennett DA; Beckett LA; Murray AM; Shannon KM; Goetz CG; Pilgrim DM; Evans DA
N Engl J Med; 1996 Jan; 334(2):71-6. PubMed ID: 8531961
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.
Ha AD; Brown CH; York MK; Jankovic J
Parkinsonism Relat Disord; 2011 Sep; 17(8):625-8. PubMed ID: 21689962
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain.
Benito-León J; Bermejo-Pareja F; Rodríguez J; Molina JA; Gabriel R; Morales JM;
Mov Disord; 2003 Mar; 18(3):267-274. PubMed ID: 12621629
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Parkinson's disease in Sydney.
Chan DK; Cordato D; Karr M; Ong B; Lei H; Liu J; Hung WT
Acta Neurol Scand; 2005 Jan; 111(1):7-11. PubMed ID: 15595932
[TBL] [Abstract][Full Text] [Related]
30. Case ascertainment uncertainties in prevalence surveys of Parkinson's disease.
Anderson DW; Rocca WA; de Rijk MC; Grigoletto F; Melcon MO; Breteler MM; Maraganore DM
Mov Disord; 1998 Jul; 13(4):626-32. PubMed ID: 9686765
[TBL] [Abstract][Full Text] [Related]
31. Cigarette smoking in Parkinson's disease: influence on disease progression.
Alves G; Kurz M; Lie SA; Larsen JP
Mov Disord; 2004 Sep; 19(9):1087-1092. PubMed ID: 15372603
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of coffee consumption and risk of Parkinson's disease.
Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
[TBL] [Abstract][Full Text] [Related]
33. Differentiating Parkinson's disease from other parkinsonian disorders.
Alvarez MV; Evidente VG; Driver-Dunckley ED
Semin Neurol; 2007 Sep; 27(4):356-62. PubMed ID: 17701873
[TBL] [Abstract][Full Text] [Related]
34. Validity of a modified Parkinson's disease screening questionnaire in India: effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries.
Sarangmath N; Rattihalli R; Ragothaman M; Gopalkrishna G; Doddaballapur S; Louis ED; Muthane UB
Mov Disord; 2005 Dec; 20(12):1550-6. PubMed ID: 16078206
[TBL] [Abstract][Full Text] [Related]
35. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of essential tremor: a door-to-door survey in bidasoa, spain.
Bergareche A; De La Puente E; López De Munain A; Sarasqueta C; De Arce A; Poza JJ; Martí-Massó JF
Neuroepidemiology; 2001 May; 20(2):125-8. PubMed ID: 11359080
[TBL] [Abstract][Full Text] [Related]
37. Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results.
Taylor KS; Counsell CE; Harris CE; Gordon JC; Smith WC
Mov Disord; 2006 Jul; 21(7):976-82. PubMed ID: 16570298
[TBL] [Abstract][Full Text] [Related]
38. The epidemiology of Parkinson's disease in the county of Rogaland, Norway.
Tandberg E; Larsen JP; Nessler EG; Riise T; Aarli JA
Mov Disord; 1995 Sep; 10(5):541-9. PubMed ID: 8552103
[TBL] [Abstract][Full Text] [Related]
39. [Parkinsonism or Parkinson's disease unmasked by pentoxifylline?].
Serrano-Dueñas M
Neurologia; 2001 Jan; 16(1):39-42. PubMed ID: 11234661
[TBL] [Abstract][Full Text] [Related]
40. Development of a Thai Parkinson's Disease Screening Tool and the Prevalence of Parkinsonism and Parkinson's Disease, Based on a Community Survey in Bangkok.
Muangpaisan W; Siritipakorn P; Assantachai P
Neuroepidemiology; 2017; 49(1-2):74-81. PubMed ID: 28877525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
